Advanced Search

Medicare Compliance & Reimbursement

Industry Notes:

CMS Adds 16 Lab Tests to CLIA-Waived Status

Published on Sun Oct 17, 2010

Part B practices will benefit from three new tests that you'll be able to report as "CLIA-waived," thanks to an Oct. 21 CMS transmittal on the matter. According to MLN Matters article 2321, CMS will now consider these tests CLIA-waived. You'll have to append Modifier QW (CLIA-waived test) to these codes, which include the following, among others: 81003 -- Germaine Laboratories Inc. AimStrip Urine Analyzer and Mediwatch urinewatch Urine Analyzer G0434 -- UCP Biosciences, Inc. Drug Screening Test Cups, Diagnostic Test Group Clarity Multiple Drug Screen Cups, and Jant Pharmacal Accutest Drug of Abuse Urine Cup Test To read the complete article, which has an implementation date of Jan. 3, 2012, visit https://www.cms.gov/transmittals/downloads/R2321CP.pdf. Keep a Careful Eye on Your Vaccination Reimbursement Pay attention to your claims for flu vaccinations, or you may be losing Medicare reimbursement that's rightfully yours. "For September claims, influenza vaccinations were priced using the 2010-2011 influenza season [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All